According to The Lemelson-MIT Program the Prize "recognizes individuals who translate their ideas into inventions and innovations that improve the world in which we live....Dubbed the "Oscar for Inventors," the Lemelson-MIT Prize is awarded to outstanding mid-career inventors who have developed a patented product or process of significant value to society, which has been adopted for practical use, or has a high probability of being adopted."
Professor Quake's group has pursued two main avenues of technology development in order to improve biological measurement techniques. The first has been the development of the biological equivalent of the integrated circuit: microfluidic large scale integration (LSI). The second technology avenue it has pursued for precision measurement is the development and application of ultra high throughput DNA sequencing technology."
Patent Portfolio Interconnection Map of Quake Patents
As of June 2012 Professor Quake was listed as an inventor on 86 issued U.S. patents and 79 published pending U.S. patent applications.
This IPVision Patent Portfolio Interconnection Map shows the U.S. patents and applications of Stephen Quake and the citation relationships within the portfolio. Note: Click on the Patent Map Image to View an Interactive Patent Map
The Quake patents have been cited by 647 other U.S. patents owned by over 200 companies and universities. These include 43 patents owned by Fluidigm Corporation (co-founded by Dr. Quake), 32 owned by Intel and 27 owned by The Invention Science Fund, managed by Intellectual Ventures LLC .
IPVision Report Provided to Lemelson-MIT Prize Committee
IPVision provided the Lemelson-MIT Prize Committee with patent analysis reports on each of the semi-finalist and finalist nominees for the 2012 Lemelson-MIT Prize. Obtain a free copy of the IPVision Patent Analysis Report on Stephen Quake.
Author: Joseph G. Hadzima, Jr. | Senior Lecturer, MIT Sloan School of Management | President of IPVision, Inc.
